TrialESMO open2022

Quality of life with encorafenib plus cetuximab with or without binimetinib treatment in patients with BRAF V600E-mutant metastatic colorectal cancer: patient-reported outcomes from BEACON CRC.

S Kopetz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.